Estimates Revisions Fulgent Genetics, Inc.
Stocks
FLGT
US3596641098
Healthcare Facilities & Services
|
Market Closed -
Nasdaq
16:00:00 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 19.61 USD | -1.70% |
|
-1.46% | -25.35% |
| 07-30 | Fulgent Genetics, Inc., Q2 2026 Earnings Call, Jul 30, 2026 | |
| 07-30 | Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022. | CI |
Turnover - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
EBIT
- Stock Market
- Stocks
- FLGT Stock
- Consensus Fulgent Genetics, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
